Related Experiment Videos
Chronic hyperglycemia and the human fetal beta cell
Pancreas
|November 1, 1993
Summary
Human fetal beta cells do not mature in vitro with high glucose exposure, unlike rodent cells. Chronic insulin release improved, but acute insulin response to glucose did not, suggesting limited in vitro maturation potential.
Area of Science:
- Endocrinology
- Developmental Biology
- Pancreatic Islet Research
Background:
- Immature rodent fetal beta cells enhance insulin release after chronic high glucose exposure in vitro.
- Human infants of diabetic mothers exhibit more mature insulin release patterns.
Purpose of the Study:
- To investigate if human fetal beta cells mature similarly to rodent cells when exposed to high glucose concentrations in vitro.
- To assess the impact of chronic glucose exposure on human fetal pancreatic explant function.
Main Methods:
- Organ culture of human fetal pancreatic explants.
- Exposure to varying glucose concentrations (0-30 mM) for six weeks.
- Assessment of insulin release, proinsulin levels, insulin content, and response to theophylline.
Main Results:
- Chronic exposure to high glucose (up to 30 mM) did not enhance the acute insulin response to glucose in human fetal explants.
- Chronic insulin release was enhanced, but similarly at 2.8 mM and 30 mM glucose.
- Insulin content increased in explants cultured with 5.6-30 mM glucose, but not 2.8 mM.
- Rat fetal pancreatic explants showed maturation with 11.2 mM glucose exposure.
Conclusions:
- Human fetal beta cells show limited in vitro maturation in response to high glucose compared to rodent models.
- Chronic glucose exposure affects basal insulin release and content but not acute glucose-stimulated insulin secretion in human fetal pancreatic tissue.
- Findings suggest species-specific differences in fetal beta cell maturation pathways.